Back
Xeris Biopharma Holdings Vs. ePlus Industry Stock Comparison
Buy
77
XERS
Xeris Biopharma Holdings
Last Price:
3.06
Seasonality Move:
-0.27%
Sell
27
PLUS
ePlus
Last Price:
80.50
Seasonality Move:
20.86%
Buy
77
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $3.15. The Score for XERS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.15
The current trend is moderately bearish and XERS is experiencing selling pressure, which indicates risk of future bearish movement.
PLUS Stock Price Chart
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 50.18 | Buy |
| Chaikin Money Flow: | -1864095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3 - 3.3) | Sell |
| Bollinger Bands (100): | (2.37 - 3.07) | Buy |
PLUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.37 | Sell |
| Relative Strength Index (14 RSI): | 28.12 | Sell |
| Chaikin Money Flow: | -371573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.15 - 100.85) | Sell |
| Bollinger Bands (100): | (81.19 - 98.29) | Sell |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Sell |
| 20-day SMA: | 3.2 | Sell |
| 50-day SMA: | 2.99 | Buy |
| 200-day SMA: | 2.49 | Buy |
| 8-day EMA: | 3.24 | Sell |
| 20-day EMA: | 3.19 | Sell |
| 50-day EMA: | 3.01 | Buy |
| 200-day EMA: | 2.57 | Buy |
PLUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.25 | Sell |
| 20-day SMA: | 94.97 | Sell |
| 50-day SMA: | 95.27 | Sell |
| 200-day SMA: | 83.59 | Sell |
| 8-day EMA: | 92.26 | Sell |
| 20-day EMA: | 94.28 | Sell |
| 50-day EMA: | 94.05 | Sell |
| 200-day EMA: | 84.44 | Sell |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
Xeris Biopharma Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ePlus Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||